| Michael Ann Benchoff, MSW | |
|
421 Sw Oak Street, Suite 520, Portland, OR 97204 | |
| (503) 988-4949 | |
| Not Available |
| Full Name | Michael Ann Benchoff |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 421 Sw Oak Street, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003065160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Ann Benchoff, MSW 3907 N. Gantenbein, Portland, OR 97227-1418 Ph: (503) 803-1784 | Michael Ann Benchoff, MSW 421 Sw Oak Street, Suite 520, Portland, OR 97204 Ph: (503) 988-4949 |
News Archive
Researchers have shown that a peptide (a chain of amino acids) called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate and pancreatic cancers in mice, achieving the same therapeutic effect as a normal dose with one-third as much of the drug.
BioMed Realty Trust, Inc. today announced that it has expanded its strategic real estate partnership with Isis Pharmaceuticals, Inc. BioMed extended its lease for Isis' current facility at Faraday Avenue in Carlsbad, California and added a lease for a new build-to-suit project, increasing the total leased space to approximately 204,700 square feet.
Today's headlines include reports about how the health law's insurance expansion could cause stress among health care providers and strain within the health system.
On January 26, 2010, the Food and Drug Administration (FDA) released a key draft guidance document, Guidance for Industry Assessment of Abuse Potential of Drugs. When finalized, this guidance will represent the FDA's current position on the abuse potential of drugs. Noteworthy within the document, Good Laboratory Practices (GLP) specified in the Guidance for Industry S7A Safety 471 Pharmacology Studies for Human Pharmaceuticals and in FDA regulations, 21 CFR 472 part 58, now also apply to abuse potential studies in animals.
As many states open CHIP programs to provide coverage for children of some state employees, the halting of CLASS Act implementation means consumers must carefully consider their long-term care options.
› Verified 8 days ago
Deanna Gold, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 847 Ne 19th Ave, Suite 100, Portland, OR 97232 Phone: 503-891-9937 | |
Loren Dale Horton, B.A, M.DIV. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1320 Sw Washington St, Portland, OR 97205 Phone: 503-535-1150 | |
Michael Peter Kender, MA, M.ED Counselor Medicare: Not Enrolled in Medicare Practice Location: 9111 Ne Sunderland Ave, Portland, OR 97211 Phone: 503-280-6646 Fax: 503-280-6051 | |
Laura Ann Allen, MS, CADCIII Counselor Medicare: Not Enrolled in Medicare Practice Location: 324 Nw Davis St, Portland, OR 97209 Phone: 503-226-2203 Fax: 503-223-4231 | |
James Paul Bryant, LCSW, CADC 3 Counselor Medicare: Not Enrolled in Medicare Practice Location: 3550 N Interstate Ave, Portland, OR 97227 Phone: 503-964-0000 | |
Lynn A Fontana, L.M.F.T, PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 8035 Ne Prescott St, Portland, OR 97218 Phone: 503-223-7719 Fax: 503-255-4714 |